New report provides analysis on biodefense sector growth

The Biodefense Market Report 2006: Vaccines, Therapeutics and Diagnostics for Bioterror Agents is the definitive study on the state of the biodefense industry. Written by the independent consulting firm BioAbility and published by the editors of BioWorld Today, this report is the only complete resource available providing hard data and information on the companies, markets, and products targeted against the U.S. Centers for Disease Control and Prevention's list of potential bioterror agents. The Biodefense Market Report provides detailed background information on these diseases, their causative agents, their incidence and prevalence worldwide, with potential and current unmet market needs analyzed. It provides useful information regarding competitors working within this emerging market, by means of company and product profiles, and enables you to learn who the players are and the stages of their products in development. The report covers 240 companies, organizations, or institutions. The report also features 51 tables, making it an easy-to-use reference for customized reports and presentations. Some of the tables and charts included: * Bioterror agent genomes sequenced * Incidence rates and information for bioterror agents * Vaccines in development, in trials and recently marketed for each bioterror agent (158 vaccines total) * Therapeutics in development, in trials and recently marketed for each bioterror agent (155 therapeutics total) * Diagnostics available and in development for bioterror agents * And more! "Source":[ http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher?next=bioMarket57514]

---